Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial
Key Abstracts/Publication in ER+ve Breast Cancer
Chairpersons :
Dr. Ranga Rao, Dr. Sudha Sinha
Speaker :
Dr. Akash Jha